PERIPHERAL NEUROPATHIES
-
Peripheral neuropathy is the result of damages of the peripheral nervous system. These disorders can be caused either by a trauma or diseases as for example diabetes.
NEUROFIT proposes animal and cellular models useful for the evaluation of the neuroprotective activity of your coumpounds.
CISPLATIN : model of chemotherapy induced neuropathy
Cisplatin is widely used as an antimitotic drug for treating various cancers. However, its employment is often limited by their neurotoxicity, including peripheral neuropathy.
Neurofit developed this model to assess the neuroprotective properties of compounds aiming to counteract chemotherapy side effects.
-
Compound testing
Neuroprotectant are usually tested in this model but other treatments could also be considered. Please feel free to contact us to discuss the feasibility of your study.
-
Endpoints
☐ Neuronal survival dose response curve (phosphatase acid activity)
☐ Neuronal death dose response curve (LDH activity)
-
-
Survival
Cisplatin induces cell death in a dose dependant manner.
At each dose tested, NGF at 5 ng/ml is able to protect neurons against ciplatin damage. -
Phosphatase acid
Cisplatin induces cell death in embryonic sensory neurons and Schwann cells co-culture. NGF at 5 ng/ml is able to protect neurons against the cisplatin damage.
-
-
Purified cultures of sensory neurons :
Cisplatin induced cell death in sensory neurons.
At each dose of cisplatin, NGF at 5 ng/ml is able to protect neurons against the ciplatin damage. -
You could also be interested in
-
Basal condition
Sensory neurons and Schwann cells co-culture from rat embryos.
Purified sensory neurons culture from rat embryos or from adult rat. -
Taxol treatment
Peripheral neuropathy is the result of damages of the peripheral nervous system induced by insult such as the neurotoxicity of taxol.
Vincristine treatment
Neurofit developed this model to assess the neuroprotective properties of compounds aiming to counteract chemotherapy side effects.